Allysine-Targeted Molecular MRI Enables Early Prediction of Chemotherapy Response in Pancreatic Cancer

已完结 10 由 zm 发布于 2024/8/12 11:38:58

DOI:10.1158/0008-5472.can-23-3548
作者：Hua Ma, Shadi A. Esfahani, Shriya Krishna, Bahar Ataeinia, Iris Y. Zhou, Nicholas J. Rotile, Jonah Weigand-Whittier, Avery T. Boice, Andrew S. Liss, Kenneth K. Tanabe, Peter Caravan
文献类型：期刊论文
补充材料：只需要正文

American Association for Cancer Research (AACR)

Abstract：Neoadjuvant therapy (NAT) is routinely used in pancreatic ductal adenocarcinoma (PDAC), but not all tumors respond to this treatment. Current clinical imaging techniques are not able to prec

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:SpringerBiotransformation of ginsenoside compound K using β-glucosidase in deep eutectic solvents.